课题基金 / 基金详情

THE EFFECTS OF ALENDRONATE ON BONE METABOLISM IN PATIENTS WITH CYSTIC FIBROSIS

THE EFFECTS OF ALENDRONATE ON BONE METABOLISM IN PATIENTS WITH CYSTIC FIBROSIS
阿仑膦酸钠对囊性纤维化患者骨代谢的影响
批准号：
6245079
负责人：
ROBERT M ARIS
金额：
$1.34万
依托单位：
UNIV OF NORTH CAROLINA CHAPEL HILL
依托单位国家：
美国
项目类别：
财政年份：
1997
资助国家：
美国
项目状态：
已结题
起止时间：
1997-01-06 至 1997-11-30
来源：
https://reporter.nih.gov/project-details/6245079
关键词：
bone metabolism clinical research cystic fibrosis drug screening /evaluation human subject human therapy evaluation inhibitor /antagonist metabolism disorder chemotherapy oral administration physiologic bone resorption

项目摘要

项目成果

ROBERT M ARIS的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
This is a randomized study of the effect of alendronate, an effective bone resorption inhibitor, on indicators of bone metabolism in adult cystic fibrosis patients. We expect to demonstrate that alendronate slows bone break-down as the first phase of a study design to evolve into an efficacy study if alendronate demonstrates acceptable oral bioavailability in CF patients.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Bisphosphonates on Bone Mineral Density in Patients with Cystic Fibrosis
The Effects of Alendronate on Bone Metabolism in Patients with CF
EFFECTS OF ALENDRONATE ON BONE METABOLISM IN PATIENTS WITH CYSTIC FIBROSIS
PAMIDRONATE ON BONE DENSITY IN PATIENTS WITH CYSTIC FIBROSIS
海外基金